Guang-Hui Liu

Guang-Hui Liu

Auto-generated profile, based on publicly available information

Guang-Hui Liu

State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2022 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
KWKang Wang
Kang Wang
HLHuicong Liu
Huicong Liu
QHQinchao Hu
Qinchao Hu
LWLingna Wang
Lingna Wang
JLJiaqing Liu
Jiaqing Liu
GLGuang-Hui Liu
Guang-Hui Liu
Aging is accompanied by the decline of organismal functions and a series of prominent hallmarks, including genetic and epigenetic alterations. These aging-associated epigenetic changes include DNA methylation, histone modification, chromatin remodeling, non-coding RNA (ncRNA) regulation, and RNA modification, all of which participate in the regulation of the aging process, and hence contribute to aging-related diseases. Therefore, understanding the epigenetic mechanisms in aging will provide new avenues to develop strategies to delay aging. Indeed, aging interventions based on manipulating epigenetic mechanisms have led to the alleviation of aging or the extension of the lifespan in animal models. Small molecule-based therapies and reprogramming strategies that enable epigenetic rejuvenation have been developed for ameliorating or reversing aging-related conditions. In addition, adopting health-promoting activities, such as caloric restriction, exercise, and calibrating circadian rhythm, has been demonstrated to delay aging. Furthermore, various clinical trials for aging intervention are ongoing, providing more evidence of the safety and efficacy of these therapies. Here, we review recent work on the epigenetic regulation of aging and outline the advances in intervention strategies for aging and age-associated diseases. A better understanding of the critical roles of epigenetics in the aging process will lead to more clinical advances in the prevention of human aging and therapy of aging-related diseases.

1 February 2020 in Cell
Verified
Journal Article
Closed access
SWSi Wang
Si Wang
YZYuxuan Zheng
Yuxuan Zheng
JLJingyi Li
Jingyi Li
YYYang Yu
Yang Yu
WZWeiqi Zhang
Weiqi Zhang
GLGuang-Hui Liu
Guang-Hui Liu

5 June 2015 in Science
Verified
Journal Article
Closed access
PDF file
WZWeiqi Zhang
Weiqi Zhang
JLJingyi Li
Jingyi Li
KSKeiichiro Suzuki
Keiichiro Suzuki
JQJing Qu
Jing Qu
PWPing Wang
Ping Wang
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
Heterochromatin in aging stem cells: Analysis of human aging syndromes, such as Werner syndrome (WS), may lead to greater understanding of both premature and normal aging. Zhang et al. generated isogenic WS-specific human embryonic stem cell lines (see the Perspective by Brunauer and Kennedy). WS-mesenchymal stem cells displayed features characteristic of premature aging, including heterochromatin disorganization. WRN protein thus functions in the maintenance of heterochromatin, and heterochromatin alterations may represent a driving force of human aging. Science , this issue p. 1160 ; see also p. 1093

23 February 2011 in Nature
Verified
Journal Article
Open access
PDF file
GLGuang-Hui Liu
Guang-Hui Liu
BBBasam Z. Barkho
Basam Z. Barkho
SRSergio Ruiz
Sergio Ruiz
DDDinh Diep
Dinh Diep
JQJing Qu
Jing Qu
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
The premature ageing disorder Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic condition characterized by a rapid onset of signs associated with normal ageing, such as atherosclerosis and the degeneration of vascular smooth-muscle cells. Liu et al. report that the altered structure of the nuclear envelope and epigenetic modifications that accumulate during physiological ageing or under specific disease conditions can be restored to normalcy by reprogramming somatic cell lines established with fibroblasts from patients with HGPS as induced pluripotent stem (iPS) cells. Directed differentiation of the resulting iPS cells as vascular smooth-muscle cells then leads to the appearance of the premature senescence phenotypes associated with vascular ageing. This HGPS iPS cell model provides a way to study the mechanisms regulating premature and normal ageing in vitro. Hutchinson–Gilford progeria syndrome (HGPS) is a rare and fatal human premature ageing disease1,2,3,4,5, characterized by premature arteriosclerosis and degeneration of vascular smooth muscle cells (SMCs)6,7,8. HGPS is caused by a single point mutation in the lamin A (LMNA) gene, resulting in the generation of progerin, a truncated splicing mutant of lamin A. Accumulation of progerin leads to various ageing-associated nuclear defects including disorganization of nuclear lamina and loss of heterochromatin9,10,11,12. Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts obtained from patients with HGPS. HGPS-iPSCs show absence of progerin, and more importantly, lack the nuclear envelope and epigenetic alterations normally associated with premature ageing. Upon differentiation of HGPS-iPSCs, progerin and its ageing-associated phenotypic consequences are restored. Specifically, directed differentiation of HGPS-iPSCs to SMCs leads to the appearance of premature senescence phenotypes associated with vascular ageing. Additionally, our studies identify DNA-dependent protein kinase catalytic subunit (DNAPKcs, also known as PRKDC) as a downstream target of progerin. The absence of nuclear DNAPK holoenzyme correlates with premature as well as physiological ageing. Because progerin also accumulates during physiological ageing6,12,13, our results provide an in vitro iPSC-based model to study the pathogenesis of human premature and physiological vascular ageing.

1 June 2016 in Cell
Verified
Journal Article
Closed access
NKNard Kubben
Nard Kubben
WZWeiqi Zhang
Weiqi Zhang
LWLixia Wang
Lixia Wang
TVTy C. Voss
Ty C. Voss
JYJiping Yang
Jiping Yang
TMTom Misteli
Tom Misteli

4 February 2020 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
WZWeiqi Zhang
Weiqi Zhang
JQJing Qu
Jing Qu
GLGuang-Hui Liu
Guang-Hui Liu
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte